세계의 파종성 혈관 내 응고(DIC) 시장 보고서(2025년)

Disseminated intravascular coagulation (DIC) is a severe, life-threatening condition marked by excessive blood clotting, which eventually leads to significant bleeding due to the depletion of clotting factors and platelets. It is triggered by underlying conditions such as sepsis, trauma, malignancies, and obstetric complications.

The primary treatments for disseminated intravascular coagulation (DIC) include medications, transfusions, surgery, and other therapeutic approaches. Medications consist of anticoagulants, blood products, and supportive drugs aimed at managing clotting and bleeding complications related to DIC. Diagnostic methods include a complete blood count with blood smear examination, partial thromboplastin time (PTT), fibrinogen blood test, D-dimer test, and other diagnostic procedures. These tests are administered through various routes, such as oral, parenteral, and alternative methods, and are distributed through hospital pharmacies, retail pharmacies, and online pharmacies. Treatment options are utilized across hospitals, specialty clinics, homecare settings, and other healthcare facilities.

The disseminated intravascular coagulation (DIC) market research report is one of a series of new reports from The Business Research Company that provides disseminated intravascular coagulation (DIC) market statistics, including the disseminated intravascular coagulation (DIC) industry's global market size, regional shares, competitors with a disseminated intravascular coagulation (DIC) market share, detailed disseminated intravascular coagulation (DIC) market segments, market trends and opportunities, and any further data you may need to thrive in the disseminated intravascular coagulation (DIC) industry. This disseminated intravascular coagulation (DIC) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The disseminated intravascular coagulation (DIC) market size has grown strongly in recent years. It will grow from $0.46 billion in 2024 to $0.49 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth during the historic period can be attributed to the increasing prevalence of sepsis, a rise in trauma cases, a growing incidence of cancer, higher healthcare expenditures, improved awareness among healthcare professionals, and the increased adoption of targeted therapies.

The disseminated intravascular coagulation (DIC) market size is expected to see strong growth in the next few years. It will grow to $0.59 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth during the forecast period can be attributed to the rising adoption of targeted therapies, increased focus on early disease detection, growing investments in healthcare infrastructure, expansion of clinical research on coagulopathy treatments, and greater awareness of rare hematological conditions. Key trends include advancements in diagnostic assays, adoption of novel anticoagulant therapies, the rise of personalized medicine approaches, integration of AI in diagnostics, improved patient monitoring technologies, and the development of targeted treatments.

The rising incidence of cancer is expected to drive the growth of the disseminated intravascular coagulation (DIC) market. Cancer is a disease characterized by the uncontrolled proliferation and spread of abnormal cells, which can invade and damage normal tissues. The increasing number of cancer cases is attributed to factors such as an aging population, lifestyle changes, environmental exposure, infections, and genetic predisposition. Cancer can lead to disseminated intravascular coagulation (DIC) by excessively activating the coagulation cascade through tumor-produced procoagulant substances, resulting in widespread clotting and bleeding. For example, in May 2024, the National Cancer Institute, a US-based government agency, reported that in 2022, approximately 20 million new cancer cases and 9.7 million cancer-related deaths were recorded globally. Projections indicate that these figures could rise to 29.9 million new cases and 15.3 million deaths annually by 2040. As a result, the increasing prevalence of cancer is fueling the growth of the disseminated intravascular coagulation (DIC) market.

Leading companies in the disseminated intravascular coagulation (DIC) market are advancing coagulation diagnostic technologies, such as next-generation blood clotting tests, to improve diagnostic accuracy, speed, and convenience. These innovations enable timely intervention and enhance patient outcomes. Next-generation blood clotting tests are advanced diagnostic tools designed to assess blood coagulation more precisely, efficiently, and comprehensively than traditional methods. For instance, in June 2022, LumiraDx Limited, a UK-based healthcare company, expanded its cardiovascular testing portfolio by obtaining CE Mark approvals for its NT-proBNP and updated D-Dimer tests. These enhancements strengthen the LumiraDx Platform's ability to assist clinicians in diagnosing heart failure and ruling out venous thromboembolism at the point of care. Such advancements aim to improve the early detection and management of cardiovascular and thrombotic conditions, including disseminated intravascular coagulation (DIC).

In March 2024, MediLink Therapeutics (Suzhou) Co. Ltd., a China-based biotech company, entered into a collaboration with Amgen Inc. to evaluate YL201 for the treatment of thrombotic disorders, including disseminated intravascular coagulation (DIC). This partnership seeks to advance blood clotting therapies, improving treatment effectiveness and patient outcomes. Amgen Inc. is a US-based biopharmaceutical company specializing in the discovery, development, and manufacturing of innovative therapeutics.

Major players in the disseminated intravascular coagulation (DIC) market are Nihon Kohden Corporation, Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., AbbVie Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, Thermo Fisher Scientific Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Danaher Corporation, Eli Lily and Company, Siemens Healthineers, Teva Pharmaceutical Industries Ltd., Mylan N.V., Grifols S.A., Eisai Co. Ltd., Beckman Coulter Inc., Sysmex Corporation, and Bio-Rad Laboratories Inc.

North America was the largest region in the disseminated intravascular coagulation (DIC) market in 2024. The regions covered in disseminated intravascular coagulation (DIC) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the disseminated intravascular coagulation (DIC) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The disseminated intravascular coagulation (DIC) market consists of revenues earned by entities by providing services such as pharmaceutical treatments, anticoagulant therapies, diagnostic services, and critical care interventions. The market value includes the value of related goods sold by the service provider or included within the service offering. The disseminated intravascular coagulation (DIC) market also includes sales of diagnostic tools, anticoagulant medications, and blood products such as platelets, fresh frozen plasma, or cryoprecipitate. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Disseminated Intravascular Coagulation (DIC) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on disseminated intravascular coagulation (dic) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for disseminated intravascular coagulation (dic) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The disseminated intravascular coagulation (dic) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment: Medicines; Transfusions; Surgery; Other Treatments
• 2) By Diagnosis: Complete Blood Count With Blood Smear Exam; Partial Thromboplastin Time (PTT); Fibrinogen Blood Test; D-dimer; Other Diagnoses
• 3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
• 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
• 5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
• Subsegments:
• 1) By Medicines: Anticoagulants; Antiplatelet Drugs; Fibrinolytics; Procoagulants; Antithrombin Therapy
• 2) By Transfusions: Platelet Transfusion; Fresh Frozen Plasma (FFP); Cryoprecipitate Transfusion; Red Blood Cell Transfusion
• 3) By Surgery: Surgical Removal Of Thrombus; Organ Surgery
• 4) By Other Treatments: Plasma Exchange; Supportive Care; Steroid Therapy
• Companies Mentioned: Nihon Kohden Corporation; Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Disseminated Intravascular Coagulation (DIC) Market Characteristics

3. Disseminated Intravascular Coagulation (DIC) Market Trends And Strategies

4. Disseminated Intravascular Coagulation (DIC) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Disseminated Intravascular Coagulation (DIC) Growth Analysis And Strategic Analysis Framework

• 5.1. Global Disseminated Intravascular Coagulation (DIC) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Disseminated Intravascular Coagulation (DIC) Market Growth Rate Analysis
• 5.4. Global Disseminated Intravascular Coagulation (DIC) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Disseminated Intravascular Coagulation (DIC) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Disseminated Intravascular Coagulation (DIC) Total Addressable Market (TAM)

6. Disseminated Intravascular Coagulation (DIC) Market Segmentation

• 6.1. Global Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medicines
• Transfusions
• Surgery
• Other Treatments
• 6.2. Global Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Complete Blood Count with Blood Smear Exam
• Partial Thromboplastin Time (PTT)
• Fibrinogen Blood Test
• D-dimer
• Other Diagnoses
• 6.3. Global Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Other Routes Of Administration
• 6.4. Global Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• 6.5. Global Disseminated Intravascular Coagulation (DIC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Homecare
• Other End-Users
• 6.6. Global Disseminated Intravascular Coagulation (DIC) Market, Sub-Segmentation Of Medicines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anticoagulants
• Antiplatelet Drugs
• Fibrinolytics
• Procoagulants
• Antithrombin Therapy
• 6.7. Global Disseminated Intravascular Coagulation (DIC) Market, Sub-Segmentation Of Transfusions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Platelet Transfusion
• Fresh Frozen Plasma (FFP)
• Cryoprecipitate Transfusion
• Red Blood Cell Transfusion
• 6.8. Global Disseminated Intravascular Coagulation (DIC) Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgical Removal Of Thrombus
• Organ Surgery
• 6.9. Global Disseminated Intravascular Coagulation (DIC) Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Plasma Exchange
• Supportive Care
• Steroid Therapy

7. Disseminated Intravascular Coagulation (DIC) Market Regional And Country Analysis

• 7.1. Global Disseminated Intravascular Coagulation (DIC) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Disseminated Intravascular Coagulation (DIC) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Disseminated Intravascular Coagulation (DIC) Market

• 8.1. Asia-Pacific Disseminated Intravascular Coagulation (DIC) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Disseminated Intravascular Coagulation (DIC) Market

• 9.1. China Disseminated Intravascular Coagulation (DIC) Market Overview
• 9.2. China Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Disseminated Intravascular Coagulation (DIC) Market

• 10.1. India Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Disseminated Intravascular Coagulation (DIC) Market

• 11.1. Japan Disseminated Intravascular Coagulation (DIC) Market Overview
• 11.2. Japan Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Disseminated Intravascular Coagulation (DIC) Market

• 12.1. Australia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Disseminated Intravascular Coagulation (DIC) Market

• 13.1. Indonesia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Disseminated Intravascular Coagulation (DIC) Market

• 14.1. South Korea Disseminated Intravascular Coagulation (DIC) Market Overview
• 14.2. South Korea Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Disseminated Intravascular Coagulation (DIC) Market

• 15.1. Western Europe Disseminated Intravascular Coagulation (DIC) Market Overview
• 15.2. Western Europe Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Disseminated Intravascular Coagulation (DIC) Market

• 16.1. UK Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Disseminated Intravascular Coagulation (DIC) Market

• 17.1. Germany Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Disseminated Intravascular Coagulation (DIC) Market

• 18.1. France Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Disseminated Intravascular Coagulation (DIC) Market

• 19.1. Italy Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Disseminated Intravascular Coagulation (DIC) Market

• 20.1. Spain Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Disseminated Intravascular Coagulation (DIC) Market

• 21.1. Eastern Europe Disseminated Intravascular Coagulation (DIC) Market Overview
• 21.2. Eastern Europe Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Disseminated Intravascular Coagulation (DIC) Market

• 22.1. Russia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Disseminated Intravascular Coagulation (DIC) Market

• 23.1. North America Disseminated Intravascular Coagulation (DIC) Market Overview
• 23.2. North America Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Disseminated Intravascular Coagulation (DIC) Market

• 24.1. USA Disseminated Intravascular Coagulation (DIC) Market Overview
• 24.2. USA Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Disseminated Intravascular Coagulation (DIC) Market

• 25.1. Canada Disseminated Intravascular Coagulation (DIC) Market Overview
• 25.2. Canada Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Disseminated Intravascular Coagulation (DIC) Market

• 26.1. South America Disseminated Intravascular Coagulation (DIC) Market Overview
• 26.2. South America Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Disseminated Intravascular Coagulation (DIC) Market

• 27.1. Brazil Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Disseminated Intravascular Coagulation (DIC) Market

• 28.1. Middle East Disseminated Intravascular Coagulation (DIC) Market Overview
• 28.2. Middle East Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Disseminated Intravascular Coagulation (DIC) Market

• 29.1. Africa Disseminated Intravascular Coagulation (DIC) Market Overview
• 29.2. Africa Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Disseminated Intravascular Coagulation (DIC) Market Competitive Landscape And Company Profiles

• 30.1. Disseminated Intravascular Coagulation (DIC) Market Competitive Landscape
• 30.2. Disseminated Intravascular Coagulation (DIC) Market Company Profiles
  • 30.2.1. Nihon Kohden Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Disseminated Intravascular Coagulation (DIC) Market Other Major And Innovative Companies

• 31.1. Merck & Co.Inc.
• 31.2. Bayer AG
• 31.3. Sanofi S.A.
• 31.4. AstraZeneca plc
• 31.5. Abbott Laboratories
• 31.6. Novartis AG
• 31.7. Thermo Fisher Scientific Inc.
• 31.8. Fresenius Kabi AG
• 31.9. GlaxoSmithKline plc
• 31.10. Danaher Corporation
• 31.11. Eli Lily and Company
• 31.12. Siemens Healthineers
• 31.13. Teva Pharmaceutical Industries Ltd.
• 31.14. Mylan N.V.
• 31.15. Grifols S.A.

32. Global Disseminated Intravascular Coagulation (DIC) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Disseminated Intravascular Coagulation (DIC) Market

34. Recent Developments In The Disseminated Intravascular Coagulation (DIC) Market

35. Disseminated Intravascular Coagulation (DIC) Market High Potential Countries, Segments and Strategies

• 35.1 Disseminated Intravascular Coagulation (DIC) Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Disseminated Intravascular Coagulation (DIC) Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Disseminated Intravascular Coagulation (DIC) Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer